FAST-Forward Trial Confirms 1-Week Breast RT at 10 Years

Published Date: 25 Jun 2026

After a decade of follow-up, a 1-week RT regimen remains noninferior to standard treatment for early breast cancer, with similar rates of recurrence and long-term adverse events.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More men with prostate cancer are avoiding unnecessary surgery

2.

Even when they are not paying attention, children are still learning.

3.

FDA Approves New Bladder Cancer First-Line Standard of Care.

4.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

5.

AI is useful in low-resource areas for triaging breast masses.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot